{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:42:52Z","timestamp":1793763772848,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG066506\\u201301"],"award-info":[{"award-number":["P30AG066506\\u201301"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tjpad.2024.100011","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:27:50Z","timestamp":1736504870000},"page":"100011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217"],"prefix":"10.1016","volume":"12","author":[{"given":"Breton M.","family":"Asken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie E. Curiel","family":"Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Crocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shellie-Anne","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franchesca","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rosselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idaly Velez","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren W.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily F.","family":"Matusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse C.","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-en","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Marsiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"DeKosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Vaillancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Duara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Loewenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tjpad.2024.100011_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"issue":"17","key":"10.1016\/j.tjpad.2024.100011_bib0002","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100011_bib0003","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41582-024-00961-z","article-title":"The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology","volume":"20","author":"Benatar","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100011_bib0004","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/awab365","article-title":"Proposed research criteria for prodromal behavioural variant frontotemporal dementia","volume":"145","author":"Barker","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2024.100011_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100011_bib0006","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","article-title":"Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures","volume":"27","author":"Palmqvist","year":"2021","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"10.1016\/j.tjpad.2024.100011_bib0007","doi-asserted-by":"crossref","first-page":"13s","DOI":"10.2967\/jnumed.121.263195","article-title":"The Role of Amyloid PET in Imaging Neurodegenerative Disorders: a Review","volume":"63","author":"Chapleau","year":"2022","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.tjpad.2024.100011_bib0008","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jamaneurol.2022.3157","article-title":"Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: a Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study","volume":"79","author":"Wilkins","year":"2022","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100011_bib0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate Use Recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100011_bib0011","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jagp.2024.01.015","article-title":"The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders","volume":"32","author":"Shaw","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-024-01386-y","article-title":"Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms","volume":"16","author":"Matuskova","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jnnp-2023-331603","article-title":"Emerging role of vascular burden in AT(N) classification in individuals with Alzheimer's and concomitant cerebrovascular burdens","volume":"95","author":"Chun","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.tjpad.2024.100011_bib0014","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/ene.15337","article-title":"Cerebrovascular disease in suspected non-Alzheimer's pathophysiology and cognitive decline over time","volume":"29","author":"Saridin","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tjpad.2024.100011_bib0015","article-title":"Do Associations Between Vascular Risk and Mild Cognitive Impairment Vary by Race?","author":"Rotblatt","year":"2021","journal-title":"J Aging Health"},{"key":"10.1016\/j.tjpad.2024.100011_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.915405","article-title":"Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease","volume":"16","author":"Saiyasit","year":"2022","journal-title":"Front Neurosci"},{"issue":"10","key":"10.1016\/j.tjpad.2024.100011_bib0017","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2024.100011_bib0018","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1002\/alz.12988","article-title":"Racial and ethnic differences in neuropsychiatric symptoms and progression to incident cognitive impairment among community-dwelling participants","volume":"19","author":"Babulal","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0019","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jalz.2016.07.151","article-title":"Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort","volume":"13","author":"Chen","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.tjpad.2024.100011_bib0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archneurol.2009.106","article-title":"Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts","volume":"66","author":"Farias","year":"2009","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0021","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/alz.13752","article-title":"Promoting diverse perspectives: addressing health disparities related to Alzheimer's and all dementias","volume":"20","author":"Maestre","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamaneurol.2022.3919","article-title":"Brain Aging Among Racially and Ethnically Diverse Middle-Aged and Older Adults","volume":"80","author":"Turney","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2024.100011_bib0023","article-title":"White matter hyperintensities in diverse populations: a systematic review of literature in the United States","volume":"6","author":"Farkhondeh","year":"2024","journal-title":"Cereb Circ Cogn Behav"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0024","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/0361073X.2010.507427","article-title":"Race-related cognitive test bias in the active study: a mimic model approach","volume":"36","author":"Aiken Morgan","year":"2010","journal-title":"Exp Aging Res"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-220684","article-title":"Cognitive Heterogeneity and Risk of Progression in Data-Driven Subtle Cognitive Decline Phenotypes","volume":"90","author":"Thomas","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2024.100011_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0028","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100011_bib0029","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","article-title":"Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set","volume":"32","author":"Besser","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100011_bib0031","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0032","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-180965","article-title":"Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury","volume":"68","author":"DeCarli","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.tjpad.2024.100011_bib0033","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jagp.2012.10.027","article-title":"Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts","volume":"21","author":"Trzepacz","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100011_bib0034","doi-asserted-by":"crossref","first-page":"e12617","DOI":"10.1002\/dad2.12617","article-title":"Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adults","volume":"16","author":"Asken","year":"2024","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0035","doi-asserted-by":"crossref","first-page":"838","DOI":"10.14283\/jpad.2024.125","article-title":"Longitudinal Trajectories of the Cognitive Function Index in the A4 Study","volume":"11","author":"Amariglio","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2024.100011_bib0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.2619","article-title":"Plasma Phosphorylated Tau 217 and A\u03b242\/40 to Predict Early Brain A\u03b2 Accumulation in People Without Cognitive Impairment","author":"Janelidze","year":"2024","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0037","doi-asserted-by":"crossref","first-page":"831","DOI":"10.14283\/jpad.2024.124","article-title":"Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4","volume":"11","author":"Molina-Henry","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2024.100011_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14100","article-title":"Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample","author":"Du","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"Pt 12","key":"10.1016\/j.tjpad.2024.100011_bib0039","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1093\/brain\/awv283","article-title":"Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings","volume":"138","author":"Jack","year":"2015","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100011_bib0040","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/alz.13770","article-title":"Minimal clinically important difference in Alzheimer's disease: rapid review","volume":"20","author":"Muir","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"13","key":"10.1016\/j.tjpad.2024.100011_bib0041","doi-asserted-by":"crossref","first-page":"e1288","DOI":"10.1212\/WNL.0000000000012600","article-title":"Data-Driven vs Consensus Diagnosis of MCI: enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes","volume":"97","author":"Edmonds","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100011_bib0042","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"issue":"5\u20136","key":"10.1016\/j.tjpad.2024.100011_bib0043","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000365548","article-title":"Patterns of hippocampal tau pathology differentiate neurodegenerative dementias","volume":"38","author":"Milenkovic","year":"2014","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0044","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-018-0369-8","article-title":"A biomarker study in long-lasting amnestic mild cognitive impairment","volume":"10","author":"Cerami","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100011_bib0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100011_bib0046","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00401-018-1872-5","article-title":"Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study","volume":"136","author":"Robinson","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-023-02570-4","article-title":"Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults","volume":"146","author":"Yu","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2024.100011_bib0048","first-page":"1","article-title":"Neuropsychiatric symptoms as a prodromal factor in Alzheimer's type neurodegenerative disease: a scoping review","author":"Ferreira","year":"2023","journal-title":"Clin Neuropsychol"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0049","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14283\/jpad.2023.125","article-title":"CTAD Task Force Paper: neuropsychiatric Symptoms in AD: clinical Trials Targeting Mild Behavioral Impairment: a Report from the International CTAD Task Force","volume":"11","author":"Soto","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2024.100011_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102768","article-title":"ARTS: a novel In-vivo classifier of arteriolosclerosis for the older adult brain","volume":"31","author":"Makkinejad","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"8","key":"10.1016\/j.tjpad.2024.100011_bib0051","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/alz.12974","article-title":"Placental growth factor as a sensitive biomarker for vascular cognitive impairment","volume":"19","author":"Hinman","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.tjpad.2024.100011_bib0052","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2024.100011_bib0053","article-title":"Prevalence of Concomitant Pathologies in Parkinson's Disease: implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms","author":"Walker","year":"2023","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100011_bib0054","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1002\/alz.13793","article-title":"Data-driven classification of cognitively normal and mild cognitive impairment subtypes predicts progression in the NACC dataset","volume":"20","author":"Edmonds","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0055","doi-asserted-by":"crossref","first-page":"e12192","DOI":"10.1002\/dad2.12192","article-title":"The relationship of semantic intrusions to different etiological subtypes of MCI and cognitively healthy older adults","volume":"13","author":"Kitaigorodsky","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.tjpad.2024.100011_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1336008","article-title":"Different aspects of failing to recover from proactive semantic interference predicts rate of progression from amnestic mild cognitive impairment to dementia","volume":"16","author":"Curiel Cid","year":"2024","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"10.1016\/j.tjpad.2024.100011_bib0057","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14364","article-title":"Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial","volume":"4","author":"Raman","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0058","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0891988720973755","article-title":"Validity of the Clinical Dementia Rating Scale Sum of Boxes in Staging and Detection of Cognitive Impairment in Mexican Americans","volume":"35","author":"Julayanont","year":"2022","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100011_bib0059","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1017\/S104161021200213X","article-title":"Cross-cultural differences in dementia: the Sociocultural Health Belief Model","volume":"25","author":"Sayegh","year":"2013","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100011_bib0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/geront\/45.6.783","article-title":"African American, Chinese, and Latino family caregivers' impressions of the onset and diagnosis of dementia: cross-cultural similarities and differences","volume":"45","author":"Mahoney","year":"2005","journal-title":"Gerontologist"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100011_bib0061","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41582-022-00630-z","article-title":"A cultural approach to dementia - insights from US Latino and other minoritized groups","volume":"18","author":"Vila-Castelar","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0062","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13311-022-01193-z","article-title":"Culture, Ethnicity, and Level of Education in Alzheimer's Disease","volume":"19","author":"Rosselli","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.tjpad.2024.100011_bib0063","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100011_bib0064","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: head-to-head comparison of phosphorylated tau immunoassays","volume":"19","author":"Ashton","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100011_bib0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13195-023-01302-w","article-title":"Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment","volume":"15","author":"Mundada","year":"2023","journal-title":"Alzheimers Res Ther"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:18:36Z","timestamp":1786018716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724006034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2274580724006034"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100011","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100011"}}